Inhibition of ligand-gated cation-selective channels by tamoxifen

Eur J Pharmacol. 1998 Aug 7;354(2-3):261-9. doi: 10.1016/s0014-2999(98)00454-3.

Abstract

The nonsteroidal antioestrogen tamoxifen has been shown to block a number of voltage-gated cation-selective channels but its effect on ligand-gated cation-selective channels has not been studied. We have investigated the action of tamoxifen and the related derivative toremifene on ligand-gated cationic nicotinic acetylcholine and 5-HT3 receptor channels. Tamoxifen and toremifene both inhibited cationic currents of adult-type human muscle nicotinic acetylcholine receptors expressed in Xenopus oocytes with similar IC50 values of 1.2 +/- 0.03 microM (nH = 0.84 +/- 0.02) and 1.2 +/- 0.1 microM (nH = 1.1 +/- 0.1), respectively. Tamoxifen could also block native 5-HT3 receptors in NG108-15 neuroblastoma/glioma hybrid cells with IC50 = 0.81 +/- 0.15 microM and nH of 1.3 +/- 0.3. The characteristics of block by tamoxifen at the 5-HT3 receptor were voltage- and use-independent. The inhibition of the 5-HT-evoked currents were not overcome by increasing concentrations of 5-HT consistent with a noncompetitive mechanism of block.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Estrogen Antagonists / pharmacology*
  • Hybridomas
  • Ion Channel Gating*
  • Ligands
  • Mice
  • Muscles / drug effects
  • Muscles / metabolism
  • Nicotinic Antagonists / pharmacology*
  • Rats
  • Receptors, Serotonin / drug effects*
  • Receptors, Serotonin / metabolism
  • Receptors, Serotonin, 5-HT3
  • Tamoxifen / pharmacology*

Substances

  • Estrogen Antagonists
  • Ligands
  • Nicotinic Antagonists
  • Receptors, Serotonin
  • Receptors, Serotonin, 5-HT3
  • Tamoxifen